Long-Term Survival after Orthotopic Liver Transplant: 20-year analysis at a Transplant Center in Campinas, Brazil
Authors:
- Victor Kenzo IvanoVIVictor Kenzo Ivano
- Rafaela Hamada JucáRJRafaela Hamada Jucá
- Arthur Nunes Martins NetoANArthur Nunes Martins Neto
- Fernanda KreveFKFernanda Kreve
- Tiago DinizTDTiago Diniz
- Alexandre ForattoAFAlexandre Foratto
- Derli Conceição MunhozDMDerli Conceição Munhoz
- Eduardo RiccettoEREduardo Riccetto
- Caique Fernandes AlvesCACaique Fernandes Alves
- Simone Reges PeralesSPSimone Reges Perales
- Elaine Cristina AtaideEAElaine Cristina Ataide
- Ilka de Fátima Santana F. BoinIBIlka de Fátima Santana F. Boin
Open Access
- 3 February 2025
- journal article
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 28 (1)
Abstract
Introduction: Orthotopic liver transplantation (OLT) is the primary therapy for end-stage liver disease. In Brazil, the number of liver transplants has significantly increased over the past decades, improving long-term outcomes. This study analyzes the long-term survival of patients who underwent OLT over 20 years at a reference transplant center. Methods: Medical records of 848 patients who underwent OLT between February 1995 and December 2017 were reviewed. Exclusion criteria included patients with survival below six months to minimize the impact of early postoperative complications on long-term outcomes. Thus, 174 patients were included. The analyzed variables involved the recipient, donor, graft, surgical procedure, and postoperative evolution. Survival was assessed using Kaplan–Meier analysis. Results: Among the 174 analyzed patients, 98 (56.3%) remained in outpatient follow-up, while 76 (43.7%) died. The mean age at transplantation was 47 years, and 75% of recipients were male. The main indications were viral hepatitis (59.8%) and hepatocellular carcinoma (11.6%). The mean MELD score was 18. The leading cause of death was cardiovascular events (36.4%), followed by liver disease recurrence (22.1%) and malignancies (15.6%). The mean survival time was 223 months for surviving patients and 112 months for deceased patients (p < 0.0001). Longer cold ischemia time, postoperative renal dysfunction, diabetes, and prolonged stay in the intensive care unit were associated with worse survival. Younger patients had significantly longer survival (p = 0.00007). Conclusion: The 20-year analysis demonstrated that OLT provides good long-term survival; however, factors such as diabetes, renal dysfunction, and prolonged cold ischemia time negatively impact the outcomes. Cardiovascular events and recurrence of liver disease were the leading causes of mortality.Keywords
This publication has 23 references indexed in Scilit:
- Predictors of patient survival following liver transplant in non-alcoholic steatohepatitis: A systematic review and meta-analysiseClinicalMedicine, 2022
- Recent evolution of living donor liver transplantation at Kyoto University: How to achieve a one-year overall survival rate of 99%?Hepatobiliary & Pancreatic Diseases International, 2020
- Immunosuppression in liver transplantBest Practice & Research Clinical Gastroenterology, 2020
- Trends in Liver Disease Etiology Among Adults Awaiting Liver Transplantation in the United States, 2014-2019JAMA Network Open, 2020
- New-Onset Diabetes and Preexisting Diabetes Are Associated With Comparable Reduction in Long-Term Survival After Liver Transplant: A Machine Learning ApproachMayo Clinic Proceedings, 2018
- Virgin Beta Cells Persist throughout Life at a Neogenic Niche within Pancreatic IsletsCell Metabolism, 2017
- Serum fibrosis biomarkers predict death and graft loss in liver transplantation recipientsLiver Transplantation, 2015
- Differences in long‐term survival among liver transplant recipients and the general population: A population‐based nordic studyHepatology, 2015
- Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinomaJournal of Hepatology, 2013
- Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factorsLiver Transplantation, 2010